Less Ads, More Data, More Tools Register for FREE

Pin to quick picksComputacenter Regulatory News (CCC)

Share Price Information for Computacenter (CCC)

Share Price is delayed by 15 minutes
Get Live Data
4,340.00    -116.00 (-2.60%)
Bid:
4,296.00
Ask:
4,376.00
Spread: 80.00 (1.862%)
Market Cap: £4.55b
CCC Live PriceLast checked at - London Stock Exchange

Intraday Computacenter Share Chart

Trading Statement

21 Jul 2021 07:00

RNS Number : 8984F
Computacenter PLC
21 July 2021
 

Computacenter plc

Incorporated in England

Registration number: 03110569

LEI: 549300XSXUZ1I19DB105

ISIN: GB00BV9FP302

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSE OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) No. 596/2014.

 

FOR IMMEDIATE RELEASE

Computacenter plc

Trading Update - 21st July 2021

Computacenter plc ("Computacenter" or the "Group"), a leading independent technology partner trusted by large corporate and public sector organisations, today publishes a trading update, based on unaudited financial information, for the period to 30 June 2021.

Trading across all of our major geographies has been robust throughout the first half of 2021, as noted in our 29th April trading update, with particular strength at the end of the second quarter. This means that the Group will deliver an adjusted profit before tax for the first half of 2021 circa 50% ahead of the same period last year. We have seen strong organic Technology Sourcing and Services Growth in the UK, Germany and the US.

There have been substantial supply shortages in the industry caused by the shortage of key components, and we have seen a strengthening of the pound against other currencies. Without these two factors our profitability would have been even further ahead.

We have seen particular strengths from our German operation compared to last year in Q2 due to the majority of our industrial clients now being fully operational.

We have also been extremely pleased with the financial performance from our US operations, a large part of which was only acquired during Q4 2020.

The UK showed some progress in the first half even though it had by far the most challenging comparison in the Group, following a very strong second quarter in 2020.

The integration of our newly acquired French networking business is on plan and we have seen an uptick in performance from our subsidiaries in Belgium and the Netherlands.

As we enter the second half of the year our Services backlog and more particularly our Product backlog, across all geographies, are at a record high which gives us a high degree of comfort. We do however remain concerned about product shortages within the industry and obviously further strengthening of the pound would create a stronger FX translation headwind, but we are not predicting either of these headwinds to get any worse.

After a record breaking performance in 2020, as we entered into 2021, there was some understandable scepticism as to whether Computacenter could continue with its 16 years of uninterrupted earnings per share growth. Given the performance in the first half, the current backlogs and the forecast to the end of the year, while nothing in life is ever certain and we face a stronger comparative in the second half, it is highly likely that 2021 will be another year of substantial progress for the Group.

This level of financial performance, coupled with the performance over the last 40 years, can only be achieved because Computacenter continually adapts to our rapidly changing industry in an agile manner which enables it to deliver the relevant services and solutions to its customers now and into the future.

We look forward to announcing the Group's Interim Results on Wednesday 9 September 2021.

 

Enquiries:

Computacenter plc

Mike Norris, Chief Executive

+44 1707 631601

Tony Conophy, Finance Director

+44 1707 631515

Tulchan Communications

James Macey White

+44 20 7353 4200

Matt Low

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTRMMMTMTBTTRB
Date   Source Headline
1st Aug 20246:03 pmRNSTransaction in Own Shares
1st Aug 202412:00 pmRNSTotal Voting Rights
1st Aug 202410:15 amRNSDirector/PDMR Shareholding
1st Aug 202410:15 amRNSDirector/PDMR Shareholding
31st Jul 20246:21 pmRNSTransaction in Own Shares
30th Jul 20246:22 pmRNSTransaction in Own Shares
30th Jul 202410:15 amRNSDirector/PDMR Shareholding
30th Jul 20247:00 amRNSTransaction in Own Shares
29th Jul 20247:00 amRNSTransaction in Own Shares
26th Jul 20247:10 amRNSShare Buyback Programme – 26 July 2024
26th Jul 20247:00 amRNSTrading Update and Return of Value – 26 July 2024
2nd Jul 202410:00 amRNSDirectorate Change -Confirmation of Effective Date
5th Jun 20247:00 amRNSCapital Markets Day
14th May 20242:00 pmRNSResult of AGM
1st May 20247:00 amRNSQ1 Trading Update
11th Apr 20241:00 pmRNS2023 Annual Financial Report & Notice of 2024 AGM
5th Apr 20247:00 amRNSDirectorate Change - Holding Announcement
4th Apr 20243:00 pmRNSDirector/PDMR Shareholding
27th Mar 20241:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20244:00 pmRNSDirector/PDMR Shareholding
22nd Mar 20247:00 amRNSChange of Chair
20th Mar 20247:00 amRNSFinal Results 2023
5th Feb 20241:00 pmRNSBlock listing Interim Review
24th Jan 20247:00 amRNSPre-Close Trading Statement
30th Oct 202311:00 amRNSQ3 2023 Trading Update Replacement
30th Oct 20237:05 amRNSAppointment of Corporate Broker
30th Oct 20237:00 amRNSQ3 2023 Trading Update
17th Oct 20231:00 pmRNSDirector/PDMR Shareholding
12th Sep 202311:00 amRNSDirector/PDMR Shareholding
8th Sep 20237:00 amRNSHalf-year Report
8th Aug 202311:30 amRNSBlock listing Interim Review
14th Jun 202312:00 pmRNSHolding(s) in Company
7th Jun 202312:00 pmRNSDirector/PDMR Shareholding
6th Jun 20234:00 pmRNSDirector/PDMR Shareholding
17th May 20232:00 pmRNSResult of AGM
28th Apr 20237:00 amRNSQ1 2023 Trading Update
17th Apr 20231:31 pmRNS2022 Annual Financial Report & Notice of 2023 AGM
11th Apr 20233:15 pmRNSDirector/PDMR Shareholding
4th Apr 20234:00 pmRNSDirector/PDMR Shareholding
31st Mar 20231:00 pmRNSDirector/PDMR Shareholding
31st Mar 20237:00 amRNSFinal Results 2022
28th Mar 20237:00 amRNSFY2022 results release date - UPDATE
14th Mar 20237:00 amRNSFY2022 results revised date; guidance unchanged
2nd Mar 202310:00 amRNSHolding(s) in Company
17th Feb 202310:00 amRNSHolding(s) in Company
9th Feb 20239:30 amRNSHolding(s) in Company
6th Feb 202311:15 amRNSBlock listing Interim Review
30th Jan 20237:00 amRNSPre-Close Trading Statement
9th Dec 202212:30 pmRNSDirectorate Change - Update
9th Dec 202212:00 pmRNSChange of Auditor

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.